Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
IgG1 ab1
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/29/2021
6D3
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/29/2021
4-[2-(2-Benzyloxycarbonylamino-3-t-butoxy-butyrylamino)-4-methyl-pentanoylamino]-5-(2-oxo-pyrrolidin-3-yl)-pent-2-enoic acid ethyl ester
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/28/2021
GC376
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/28/2021
8-{3-hydroxy-4-[(7-hydroxynaphthalen-2-yl)oxy]phenoxy}-1,4-benzodioxin-5-ol
Potential treatment - theoretical effect Experimental Antiviral Apr/25/2021
CA521FALA
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/23/2021
WNbFc 36
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/23/2021
WNbFc 15
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/23/2021
WNbFc 7
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/23/2021
WNbFc 2
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/23/2021
TPNT1
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/22/2021
Apabetalone
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/18/2021
PCI-27483
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/12/2021
Avoralstat
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/12/2021
Naproxol
Potential treatment - theoretical effect Experimental Other treatment Apr/12/2021
(E)-4-(4-((5-(4,5-Dimethyl-2-nitrophenyl)furan-2-yl)Methylene)-3-Methyl-5-oxo-4,5-dihydro-1H-pyrazol-1-yl)benzoic acid
Potential treatment - theoretical effect Experimental Other treatment Apr/12/2021
Teniposide
Potential treatment - theoretical effect Experimental Antiviral Apr/12/2021
NVX-CoV2373
Potential treatment - clinical evidence Experimental Vaccine Apr/07/2021
CoronaVac
Potential treatment - clinical evidence Experimental Vaccine Apr/06/2021
Adjuvanted SARS-CoV-2 Spike protein
Potential treatment - pre-clinical evidence Experimental Vaccine Apr/01/2021